In VitroPotential of Lycosin-I as an Alternative Antimicrobial Drug for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections

Investigation of in-vitro susceptibility of multidrug-resistant Acinetobacter baumannii strains isolated from clinical specimens to tigecycline

(2017) Tekin Tas et al.   Bosnian Journal of Basic Medical Sciences

Risk Factors and Outcome Analysis of Acinetobacter baumannii Complex Bacteremia in Critical Patients*

(2014) Hao-Yuan Lee et al.   CRITICAL CARE MEDICINE

Antibiotic resistance determinants of a group of multidrug-resistant Acinetobacter baumannii in China

(2014) Xu Xiao-min et al.   JOURNAL OF ANTIBIOTICS

Functional characterization of naturally occurring melittin peptide isoforms in two honey bee species, Apis mellifera and Apis cerana

(2014) Doori Park et al.   PEPTIDES

Nephrotoxicity Of Polymyxin B: Experimental Study In Cells And Implications For Nursing Practice

(2014) Luciana Barros de Moura Neiva et al.   Revista da Escola de Enfermagem da USP

New Insights into Dissemination and Variation of the Health Care-Associated Pathogen Acinetobacter baumannii from Genomic Analysis

(2014) M. S. Wright et al.   mBio

In VitroPharmacodynamics of Polymyxin B and Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii

(2013) Mao Hagihara et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

“Airborne Assault”

(2013) Brad Spellberg et al.   CRITICAL CARE MEDICINE

Antimicrobial Potential of Lycosin-I, a Cationic and Amphiphilic Peptide from the Venom of the Spider Lycosa singorensis

(2013) H. Tan et al.   CURRENT MOLECULAR MEDICINE

Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium

(2013) Felipe F. Tuon et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii

(2013) S. T. Housman et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Hetero- and adaptive resistance to polymyxin B in OXA-23-producing carbapenem-resistant Acinetobacter baumannii isolates

(2013) Juliana Barin et al.   Annals of Clinical Microbiology and Antimicrobials

A Novel Spider Peptide Toxin Suppresses Tumor Growth Through Dual Signaling Pathways

(2012) Z. Liu et al.   CURRENT MOLECULAR MEDICINE

Spread of multidrug carbapenem-resistant Acinetobacter baumannii in different wards of an Italian hospital

(2011) Maria Luisa Cristina et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Longitudinal epidemiology of multidrug-resistant (MDR) Acinetobacter species in a tertiary care hospital

(2011) Ji Hoon Baang et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Antimicrobial Peptides: Successes, Challenges and Unanswered Questions

(2011) William C. Wimley et al.   JOURNAL OF MEMBRANE BIOLOGY

Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens

(2009) Garyphallia Poulakou et al.   JOURNAL OF INFECTION

A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae

(2008) K. Vasilev et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY